Title:  Sustained release hair growth composition

United States Patent:  6,255,313

Assignee:  Taisho Pharmaceutical Co., Ltd. (JP)

Filed:  July 6, 1999

PCT NO:  PCT/JP98/00227

102(e) Date:  July 6, 1999

PCT PUB. Date:  July 30, 1998

Foreign Application Priority Data:  Jan 23, 1997[JP] (9-010531)

A sustained hair growth preparation comprising minoxidil and dipropylene glycol makes it possible to retain the absorbed minoxidil in the dermis and to increase the concentration of the minoxidil around the hair bulbs which are the hair growing sites, thereby making it possible to give a sufficient hair growth effect.

DISCLOSURE OF THE INVENTION

The present inventors have variously researched under the conception that, when minoxidil is used as a hair growth agent, it will be possible to provide a hair growth preparation having a sufficient hair growth effect with even only a once-per-day application, by allowing to retain the percutaneously absorbed minoxidil in the dermis, and thus by raising the concentration of minoxidil over a long period around the hair bulbs which are the hair growing sites.

As a result, the combination of the minoxidil-containing hair growth preparation with dipropylene glycol has been found to maintain minoxidil in the dermis for a long period of time, thus the present invention has been accomplished.

Accordingly, the present invention is directed to a sustained release hair growth preparation which comprises minoxidil and dipropylene glycol.

In the present invention, the amount of minoxidil is from 0.1 to 10% by weight, which is an ordinary amount of minoxidil used as an effective component of hair growth preparations.

In the present invention, the amount of dipropylene glycol is preferably from 5 to 40% by weight based on the total weight of the preparation. When the amount of dipropylene glycol is less than 5% by weight, the retention effect of minoxidil in the dermis is insufficient, and when the amount is more than 40% by weight, the resulting preparation gives a bad feeling in use.

Furthermore, the preparation of the present invention is preferably adjusted to a pH of 4 to 9, and especially pH 5 to 8, when diluted 20-fold with purified water. When the pH of the preparation is out of the above-mentioned range, the retention effect of minoxidil in the dermis may decrease, and skin irritation may occur.

In the hair growth preparation of the present invention, a further combination of 1,3-butylene glycol or propylene glycol with the preparation can shorten the time for reaching the maximum concentration (Tmax) of minoxidil in the dermis. Furthermore, the retention time of minoxidil in the dermis can be further prolonged by the combination of the preparation with a polar solvent selected from the group consisting of 2-hexyl-1-decanol, isooctadecanol, glycerol dicaprate, glycerol dicaprylate, glycerol monoisostearate and propylene glycol monoisostearate. Accordingly, such combination of these substances makes it possible to control the dose and the number of application times of the hair growth preparation.

In the present invention, when 1,3-butylene glycol or propylene glycol is contained therein, its amount is preferably from 0.1 to 10 parts by weight, and especially from 0.1 to 5 parts by weight per 1 part by weight of dipropylene glycol, in view of the Tmax-shortening effect and the retention effect of minoxidil in the dermis. Furthermore, when the preparation is combined with the polar solvent selected from the group consisting of 2-hexyl-1-decanol, isooctadecanol, glycerol dicaprate, glycerol dicaprylate, glycerol monoisostearate and propylene glycol monoisostearate, the amount of the polar solvent is preferably from 0.005 to 5 parts by weight, and especially from 0.01 to 2 parts by weight per 1 part by weight of dipropylene glycol, in view of the extension effect on the retention period of minoxidil in the dermis and the maximum concentration of minoxidil in the dermis.

According to the present invention, components used for ordinary hair growth preparations can be contained therein, for example, fillers, vasidilators (carpronium chloride, benzyl nicotinate, swertia herb extract, panax ginseng extract, vitamin E acetate, capsicum tincture, etc.), antihistamines (diphenhydramine hydrochloride, isothipendyl hydrochloride, etc.), anti-inflammatory agents (glycyrrhetic acid, guaiazulene, etc.), keratolytics (urea, salicylic acid, etc.), antimicrobial agents (chlorhexidine gluconate, isopropyl methyl phenol, quaternary ammonium salts, hinokitiol, piroctone olamine, etc.), humectants (sodium hyaluronate, chondroitin sulfuric acid, etc.), extracts of animals and plants (Taxus cuspidata, Paeonia suffruticosa, Glycyrrhisa uralensis, Hypericum erectum, aconite root, Eriobotrya japonica, Artemisia capillaris, Symphytum officinale, Angelica keiskei, Crocus sativus, Gardeniac Fructus, Posmarinus officinalis, Salvia officinalis, saussurea root, Aristolochia debilis, Lupuli strobilus, placenta, etc.), vitamins (retinol acetate, pyridoxine hydrochloride, ascorbic acid, thiamin nitrate, cyanocobalamin, biotin, etc.), water, lower alcohols (methanol, ethanol, denatured ethanol, isopropyl alcohol, etc.), anti-oxidants (dibutylhydroxytoluene, sodium pyrosulfite, tocopherol, disodium edetate, ascorbic acid, isopropyl gallate, etc.), solubilizers (diisopropyl adipate, isopropyl myristate, polyethylene glycol, medium chain fatty acid triglyceride, fatty acid esters, vegetable oils, animal oils, polyhydric alcohol fatty acid ester, alkyl glyceryl ether, hydrocarbons, lactic acid, sodium hydroxide, etc.), metabolic activators (panthenol, etc.), surface active agents (sorbitan fatty acid ester, glycerol fatty acid ester, polyglycerol fatty acid ester, propylene glycol fatty acid ester, polyoxyethylene sorbitan fatty acid ester, polyoxyethylene sorbitol fatty acid ester, polyoxyethylene glycerol fatty acid ester, polyethylene glycol fatty acid ester, polyoxyethylene alkyl ether, polyoxyethylene polyoxypropylene alkyl ether, polyoxyethylene alkyl phenyl ether, polyoxyethylene hydrogenated castor oil, polyoxyethylene castor oil, polyoxyethylene beeswax derivatives, polyoxyethylene lanolin derivatives, polyoxyethylene alkyl amide, polyoxyethylene alkyl amine, lecithin derivatives, high molecular emulsifiers, etc.), emulsifying stabilizers (higher alcohol, etc.), gelling agents (water-soluble high molecular compounds, etc.), thickeners, perfumes, refrigerants (menthol, mentha oil, camphor, etc.) or dyes. When water or a lower alcohol is contained herein, water content is preferably from 0.5 to 30% by weight based on the total weight of the preparation, and when ethyl alcohol or isopropyl alcohol is contained as the lower alcohol, its amount is preferably from 50 to 90% by weight based on the total weight of the preparation.

The hair growth preparation of the present invention can be produced by an ordinary method in the form of an external preparation such as creams, ointments, aerosols, lotions or tonics. In addition, the sustained release hair growth preparation of the present invention can be used by applying a suitable amount thereof percutaneously once per one to several days. Applied in this manner, the composition of the present invention is effective in treating alopecia and baldness.

Claim 1 of 10 Claims

What is claimed is:

1. A sustained release hair growth composition which comprises minoxidil and 5 to 40% by weight of dipropylene glycol based on the composition.

____________________________________________
If you want to learn more about this patent, please go directly to the U.S. Patent and Trademark Office Web site to access the full patent.